<section id ="1156051-1249395" class="mfp-hide modal-dialog modal-content overlay-def"><header class="modal-header"><h2 class="modal-title">2019, c. 29, s. 166</h2></header><div class="modal-body"><p class="Section amending" id="1156051"><strong><a class="sectionLabel" id="s-166"><span class="sectionLabel">166</span></a></strong> The Act is amended by adding the following after section 3:</p><section><div class="AmendedText"><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Prohibition — clinical trials</p><p class="Section"><strong>3.1</strong> No person shall conduct a clinical trial in respect of a drug, device or prescribed food for a special dietary purpose unless the person holds an authorization issued under the regulations that authorizes the conduct of the clinical trial.</p><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Terms and conditions — clinical trial authorizations</p><p class="Section"><strong>3.2</strong> The holder of an authorization referred to in section 3.1 shall comply with any terms and conditions of the authorization that are imposed by the Minister under regulations made under paragraph 30(1)(b.3).</p><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Duty to publicize clinical trial information</p><p class="Section"><strong>3.3</strong> The holder of an authorization referred to in section 3.1 shall ensure that prescribed information concerning the clinical trial is made public within the prescribed time and in the prescribed manner.</p></div></section></div></section>